Pediatric dermatologist Mercedes E. Gonzalez, MD, discusses roflumilast's promise as a safe, nonsteroidal treatment for atopic dermatitis in infants.
Mercedes E. Gonzalez, MD
Advertisement
Dr Gonzalez isa board certified pediatric dermatologist, a clinical assistant professor at the FIU Herbert Wertheim School of Medicine and the Phillip Frost Department of Dermatology at the Miller School of Medicine, and serves as Medical Director at Pediatric Skin Research in Miami, FL. She is also the co-editor of Goodheart's Photoguide to Common Pediatric and Adult Skin Disorders, Fourth Edition.
Articles by Mercedes E. Gonzalez, MD
Mercedes Gonzalez, MD, discusses the promising INTEGUMENT-INFANT trial, exploring a new non-steroidal treatment for infants with atopic dermatitis.
Mercedes E. Gonzalez, MD, reflects on the SPD meeting as well as challenges and advances in pediatric dermatology.
Advertisement
Latest Updated Articles
Key Insights From the SPD Pre-AAD Meeting: Advances, Challenges, and the Future of Pediatric DermatologyPublished: March 25th 2025 | Updated:
Investigating Roflumilast 0.05% Cream for Infant AD with Mercedes E. Gonzalez, MDPublished: June 17th 2025 | Updated:
Shifting the Paradigm in Infant Atopic Dermatitis Treatment With RoflumilastPublished: June 18th 2025 | Updated:
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
3
Reviewing Type 2 Inflammation Through a Different Lens
4
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
5
